$15.390
+6.602 (+42.90%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LYEL Prediction & Forecast by Similar Chart Analysis
Alphio's LYEL stock price prediction model matches the current Lyell Immunopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.37 (-6.64%). The 1-week path is $13.77 (-10.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Lyell Immunopharma Inc Stock?
Lyell Immunopharma is a good buy right now due to its current price of $10.88, which is significantly below the analyst price target of $44, indicating a potential upside of 304%. Additionally, the stock has shown a positive momentum with a 5-day change of +16.86% and a strong RSI of 69.98, suggesting bullish sentiment. The main risk is the high net loss reported for Q4 2025 of $140.7 million, which could impact investor confidence if not addressed effectively.
LYEL stock price ended at $15.39 on Wednesday, after rising +42.90%
Lyell Immunopharma Inc (LYEL) last closed at $15.3900003, gaining +42.90%. These facts feed the 1-day and 1-week LYEL price prediction above.
Forecast Drivers
Lyell Immunopharma Inc (LYEL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LYEL, ranked by similarity.
Seasonality analysis for LYEL
Historically the probability of a positive November return for LYEL is 45.24%. December offers the highest probability of a positive month at 51.16%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LYEL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $11.09 | $15.08 | $15.88 | -1.99% |
| Dec 2026 | $12.52 | $15.08 | $19.60 | -1.99% |
In 2026, Lyell Immunopharma Inc (LYEL) is projected to range from $11.09 to $19.60.
Lyell Immunopharma Inc 2026 monthly forecast
In Nov 2026, Lyell Immunopharma Inc is projected to average $15.08, with a low of $11.09 and high of $15.88.
In Dec 2026, Lyell Immunopharma Inc is projected to average $15.08, with a low of $12.52 and high of $19.60.
Related articles
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
- Democratic Sweep Sends Stocks Soaring: Dow Posts Best Post-Midterm Rally in 44 Years Amid AI Sector US stocks surged after Democrats swept the 2026 midterms. The Dow jumped 1,569 points for its best post-election day since 1982 as markets cheered political clarity.
- Stock Market Surges After 2026 Midterms: What the Democratic Sweep Means for Your PortfolioThe stock market rallied after Democrats won the 2026 midterms. Discover what the election means for investors, tech stocks, and the S&P 500 outlook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.